Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



TAKANASHI KEN Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 TAKANASHI KEN (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 45,000 options to buy @ $4.58, valued at $206.1k
06/08/2023 4 TAKANASHI KEN (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Bought 22,053,581 shares @ $0.91, valued at $20.1M
Disposed/sold 10,000 options to buy @ $26.99, valued at $269.9k
Disposed/sold 20,000 options to buy @ $4.6, valued at $92k
Disposed/sold 30,000 options to buy @ $3.46, valued at $103.8k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Granted 30,000 options to buy @ $3.46, valued at $103.8k
08/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $4.6, valued at $92k
08/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2020 4 TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Granted 10,000 options to buy @ $26.99, valued at $269.9k
09/17/2019 4 TAKANASHI KEN (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Converted 33,741 shares @ $0
Converted 307,110 shares @ $0
Bought 233,333 shares @ $15, valued at $3.5M
Converted 33,741 preferred shares @ $0
Converted 307,110 preferred shares @ $0
08/16/2019 4 TAKANASHI KEN (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 10,500 options to buy @ $20.34, valued at $213.6k
08/15/2018 4 TAKANASHI KEN (10% Owner) has filed a Form 4 on Wave Life Sciences Ltd.
Txns: Granted 9,000 options to buy @ $46.7, valued at $420.3k
08/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy